Commercialization Strategy. The commercial organizations of RMS, Epizyme, and Eisai shall work jointly, [**] to determine a joint marketing strategy and plan to align priorities and activities for launch of the RMS Product and subsequent commercialization of the RMS Product in the Major Markets for use with the Pharmaceutical Partners Product (the “Commercialization Strategy”). The Parties shall use Commercially Reasonable Efforts to collaborate on joint promotional efforts as set forth in the Commercialization Strategy.
Appears in 4 contracts
Samples: Companion Diagnostics Agreement (Epizyme, Inc.), Companion Diagnostics Agreement, Companion Diagnostics Agreement (Epizyme, Inc.)